| Name | Title | Contact Details |
|---|---|---|
Matthew Pixton |
Chief Technology Officer | Profile |
Verde Science has assembled an impressive team of scientists from highly technical disciplines including Bioprocess Technology, Nanotechnology, Molecular Virology and Immunology, Molecular Biology, Pharmacology and Medical Device Design. Our focus is the discovery of novel drugs and new treatment modalities, as well as cutting edge diagnostic devices and pharmaceutical delivery systems for the treatment of emerging diseases and contemporary medical issues where current treatments either do not exist or are inadequate. Our Research and Development program includes collaboration with our R&D alliance partners which include the Sterkem Group, an integrated pharmaceutical firm based in Mumbai, India; the Institute for Chemical Technology, a Mumbai, India based science and technology university; and our researchers based in India and Canada. We believe that this synergistic and nimble team of highly skilled scientists is the most cost-effective and efficient way to rapidly respond to the increasing array of inadequately addressed contemporary medical issues facing the world community. An initial focus is on developing custom medicinal formulations from cannabinoids and THC compounds for the treatment of specific issues such as migraines, glaucoma, loss of appetite from cancer therapies, and numerous other medical issues. Verde also plans to alpha test innovative growing technologies in India as part of the company’s initiatives.
Fluoramics Inc is a Mahwah, NJ-based company in the Manufacturing sector.
General Plastics Corp is a Bloomfield, NJ-based company in the Manufacturing sector.
Dutek Inc is a Vista, CA-based company in the Manufacturing sector.
Dyco Paints is a Clearwater, FL-based company in the Manufacturing sector.